Overview

Eradication Efficacy and Safety of Two Rescue Treatments for Helicobacter Pylori Infection

Status:
Not yet recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The aim of this study was to evaluate the efficacy and safety of high-dose dual therapy compared with furazolidone-based quadruple therapy as a rescue treatment for helicobacter pylori infection.
Phase:
N/A
Details
Lead Sponsor:
Shanghai Zhongshan Hospital
Treatments:
Amoxicillin
Bismuth
Esomeprazole
Furazolidone
Potassium Citrate